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Abstract Acute coronary syndrome (ACS) still remains one
of the leading causes of mortality and morbidity worldwide.
Seven to fifteen percent of patients presenting with ACS have
unobstructed coronary artery disease (CAD) on urgent angi-
ography. Patients with ACS and unobstructed coronary arter-
ies represent a clinical dilemma and their diagnosis and man-
agement is quite variable in current practice. Cardiovascular
magnetic resonance imaging with its unique non-invasive
myocardial tissue characterization property has the potential
to identify underlying etiologies and reach a final diagnosis.
These include acute and chronic myocarditis, embolic/
spontaneous recanalization myocardial infarction, and Tako-
Tsubo cardiomyopathy, and other conditions. Establishing a
final diagnosis has a direct implication on patient’s manage-
ment and prognosis. In this article, we have reviewed the
current evidence on the diagnostic role of cardiac magnetic
resonance (CMR) in patients with ACS and unobstructed cor-
onary arteries. We have also highlighted the potential role of
CMR as a risk stratification or prognostication tool for this
patient population.
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Introduction
Globally, acute coronary syndrome (ACS) still remains one of
the leading causes of mortality and morbidity. Emergency or
early angiography is recommended in suspected ACS with
ST-elevation myocardial infarction (STEMI) or in non-ST el-
evation ACS (NSTE-ACS) with an intermediate-high Global
Registry of Acute Coronary Events (GRACE) score. The lit-
erature suggests that 7–10 % of patients presenting with
STEMI and 10–15 % of patients presenting with NSTE-
ACS have unobstructed coronary artery disease (CAD) on
urgent angiography [1–8]. Patients with ACS and unobstruct-
ed coronary arteries represent a clinical dilemma and their
management is quite variable in current practice. Secondary
prevention medications for ACS are used less frequently in
these patients than in patients with obstructive CAD [9, 10].
This is partly due to our lack of understanding of the underly-
ing patho-physiological mechanisms leading to the troponin
rise and the lack of clear-cut guidelines. A common clinical
misconception is that patients in this group have a relatively
good prognosis in comparison with patients with an MI with
obstructive CAD; several studies have shown that the mortal-
ity rate or re-infarction is not negligible following ACS with
unobstructed CAD [8, 10–13, 14•]. A recent systematic re-
view of patients presenting with suspectedMI and unobstruct-
ed coronary arteries by Pasupathy et al. showed an overall all-
cause mortality of 4.7 % at 12 months [15••]. Several recent
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studies have shown that additional imaging like cardiac mag-
netic resonance (CMR) may be particularly useful in deter-
mining the diagnosis. Accurate diagnosis helps to tailor med-
ical treatment, for example the diagnosis of a non-ischemic
underlying etiology may obviate the need for anti-platelet and
anti-atherosclerotic therapies.
CMR in ACS and Unobstructed Coronaries
Three possible etiologies explain the clinical presentation in
up to 95 % of cases of acute chest pain, elevated troponin, and
unobstructed coronary arteries [16–18, 19••, 20•, 21••, 22•,
23•, 24•, 25•]. These include: (1) acute myocarditis, (2) acute
MI, and (3) cardiomyopathy, in particular Tako-Tsubo cardio-
myopathy (TCM). All of these conditions can be easily diag-
nosed with an appropriately tailored CMR study.
CMR diagnostic accuracy is based on the use of a number
of different sequences, which includes—long- and short-axis
cine, and T2-weighted and late gadolinium enhancement
(LGE) imaging repeated in the same slice positions as the cine
imaging. These three sequences assess the presence of region-
al wall motion abnormalities and ventricular volumes calcula-
tion, presence, and extent of myocardial edema/inflammation
and myocardial scar/fibrosis, respectively.
First-pass perfusion and T1 and T2mapping sequences can
be added depending on the clinical question or the research
interest (Table 1). This will result in a total scan duration time
of ∼45 min. [26••]
All of the three acute pathologies (myocarditis,MI, or TCM)
cause myocardial injury leading to edema. Edema in CMR
corresponds to an increase in the T2 relaxation time which
can be delineated with T2-weighted imaging [27]. There are
various sequences available for delineation of myocardial ede-
ma. T2-weighted short-tau inversion recovery (T2-STIR) is the
most commonly used sequence to image edema in clinical
practice. However, T2-STIR image quality is easily degraded
with respiratory motion or tachyarrhythmia, which are both
common in patients with ACS and unobstructed coronaries
(Fig. 1). Newer sequences such as ACUT2E (cardiac unified
T2 edema) and T2 mapping are less prone to such artefacts.
However, a recent study byMcAlindon et al. demonstrated that
the different methods for detecting and quantifying myocardial
edema are not interchangeable, and that T2 mapping was the
most reproducible method, albeit this sequence comparison
was done just in the context of STEMI [28••].
Three CMR sequences have diagnostic role in patients
suspected with myocarditis: (1) LGE sequences for detection
of myocardial necrosis and/or fibrosis, (2) T2-weighted im-
ages for assessment of myocardial edema, and (3) T1-weight-
ed sequences before and after contrast injection for detection
of myocardial hyperemia (Fig. 2). Myocardial infarction can
be diagnosed on CMR by identifying a subendocardial or
transmural LGE pattern (Fig. 3) [29] whereas TCM can be
diagnosed by the characteristic mid-apical myocardial edema
with corresponding regional wall motion abnormalities and
apical ballooning, but with no or only subtle LGE (Fig. 4).
Although a number of retrospective and prospective clini-
cal studies have reported the diagnostic role of CMR in this
patient cohort, the diagnostic pick-up rate is variable. This
could be attributed to the time delay between CMR imaging
from the acute presentation, as well as the CMR sequences
and imaging protocol used.
Role of CMR in Diagnosis
Acute Myocarditis
Several studies have shown that the commonest underlying
etiology of patients presenting with suspected ACS and unob-
structed coronary arteries is myocarditis. The prevalence of
myocarditis is variable and ranges from 15 to 75 % [16–18,
19••, 20•, 21••, 22•, 23•, 24•, 25•]. This large variation is
probably due to the CMR imaging sequences being used
and the timing of the scan from the acute presentation. The
use of T2-weighted images for assessment of myocardial
edema/inflammation and imaging patients early from the on-
set of symptoms increases the diagnostic pick-up rate given
that some abnormalities as myocardial edema/inflammation
may be reversible and resolve with time. Use of T2-
weighted images for assessment of myocardial edema and
scanning the patients within 2 weeks from the onset of symp-
tom increases the diagnostic pick up rate [30••].
The non-invasive imaging diagnosis of myocarditis and
myocardial inflammation always represented a diagnostic
challenge because diagnosis is based on indirect signs like
myocardial swelling, wall motion abnormality, and pericardial
effusion, particularly with echocardiography [31].
Endomyocardial biopsy (EMB) still represents the gold stan-
dard for the diagnosis of myocarditis. Recently, several studies
have validated CMR against EMB [18, 32••, 33], suggesting
that CMR can have a promising role in the diagnostic pathway
of these patients [34–39].
EMB is an invasive procedure and not widely available and
has several limitations including low sensitivity and specific-
ity due to sampling errors. This has fostered the increasing
interest on the role of CMR in these patients. A recent Expert
Position Statement of the European Society of Cardiology
(ESC) confirms the important diagnostic role of CMR in pa-
tients with suspected myocarditis [40••]. Whilst CMR cannot
replace EMB, there is agreement that it can be offered in
clinically stable patients prior to EMB. CMR-guided EMB,
i.e. obtaining the biopsy specimen from the LGE scar, can
improve the diagnostic rate of the disease, as demonstrated
by Mahrholdt et al. [41].
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Recently, a consensus paper has defined the recommenda-
tions on the use of CMR in myocarditis [42] which led the
establishment of the BLake Louise criteria^ diagnostic criteria.
In particular, the CMR findings are consistent with the diag-
nosis of myocarditis if two of three sequences demonstrating
myocardial edema, hyperemia, and fibrosis are positive.
Novel parametric mapping techniques like, native T1 map-
ping, extracellular volumes of distribution (ECV) and T2
mapping, currently mainly used for research, have recently
shown promising results in the diagnostic assessment of
myocarditis [43••]. Recent studies by Ferreira and Piechnik
et al. [44••, 45••] demonstrated that native T1 mapping has a
superior diagnostic role compared to conventional T2-
weighted imaging, and an equivalent performance to LGE.
Native T1 mapping can also display the typical non-
ischemic patterns in acute myocarditis, without the need for
gadolinium contrast agents [46••]. Radunski et al. recently
demonstrated the utility of ECV quantification, as a measure
of interstitial fibrosis in both acute and subacute, severe myo-
carditis [47••]. They compared the diagnostic performance of
T2, T1, and ECV as novel quantitative tissue markers com-
pared to the Lake Louise criteria. ECV quantification together
with LGE imaging significantly improved the diagnostic ac-
curacy of CMR compared with the Lake Louise criteria [47••].
Embolic MI/MI with Spontaneous Recanalisation
Acute MI with unobstructed coronary artery is a common
clinical situation and is the second most common etiology in
this cohort of patients (5–29 %) [16–18, 19••, 20•, 21••, 22•,
23•, 24•, 25•]. Several different patho-physiological mecha-
nisms have been proposed to explain this phenomenon, e.g.
rupture or erosion of a vulnerable plaque (causing transitory
occlusion that resolves spontaneously, without leaving any
residual visible intracoronary lesion), and distal vessels or
small-caliber side branches disease. Other mechanisms in-
cluding distal embolisation, coronary vasospasm, inflamma-
tion, or coronary dissections are rarely associated. Myocardial
infarction can be diagnosed on CMR by identifying either a
Table 1 CMR protocol in Patients with ACS and unobstructed
coronaries [26••]
SEQUENCES CLINICAL APPLICATION
1. Cines (short and long axis) LV/RV function
Regional wall motion
abnormality





4. Early gadolinium enhancement MVO
LV Thrombus
5. Late gadolinium enhancement Scar/fibrosis
Pattern of LGE
6. Advanced tissue characterization
sequences (e.g. T2 mapping, T1
mapping for native T1 and ECV
Myocardial edema
Myocardial fibrosis
ACS acute coronary syndrome, LV left ventricle, RV right ventricle,MVO
microvascular obstruction, LGE late gadolinium enhancement, ECV ex-
tracellular volume of distribution
Fig. 1 A 24-year old man with
acute myocarditis. a and b T2
STIR images of four- and two-
chamber long-axis views showing
non-diagnostic images due to
tachycardia. c and d T2 Mapping
images of four- and two-chamber
long-axis views showing diffuse
global myocardial edema with
sparing of the basal septum
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subendocardial or transmural LGE pattern in a typical coro-
nary artery territory [29]. CMR can provide information on
whether the myocardial infarction is acute/sub-acute
orchronic. Acute ischaemic myocardial injury leads to myo-
cardial edema, which can be delineated with T2-weighted
imaging. Establishing the diagnosis in the presence ofMI with
unobstructed coronary arteries is very important, particularly
so that appropriate management can be tailored. This can rep-
resent a plaque event or an extra-coronary embolic event.
Review of coronary angiogram and coronary plaques, and
Fig. 2 Acute myocarditis in a 38-
year male. Late gadolinium
enhancement (LGE) sequence
(white arrows) showing a patchy
and diffuse epicardial LGE in the
basal and mid-cavity lateral wall
(a). T2−weighted images of same
patient showing increased
myocardial signal intensity (red
arrows) of the basal and mid-
cavity epicardial lateral wall (b)
signifying myocardial edema
Fig. 3 A 63-year-old man with
small transmural myocardial
infarction in the distal anterior and
anterolateral walls. T2-weighted
images showing small area of
myocardial edema in the apical
anterior and lateral walls,
corresponding to the distal LAD
territory (a). LGE images
showing transmural infarction in
the distal anterior and
anterolateral walls (b)
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excluding other sources of emboli (for example: exclude a
patent foramen ovale as a potential contributor to a paradox-
ical embolic MI) often follows this diagnosis by CMR.
Patients with acute MI need long-term clinical follow-up
and secondary atherosclerotic prevention treatment. In addi-
tion, CMR can provide further valuable prognostic informa-
tion in this setting, including myocardial wall motion, global
function, perfusion, and viability.
Cardiomyopathy
Cardiomyopathy is the third common cause of suspected
ACS with unobstructed coronary arteries. According to lit-
erature TCM is the most frequent and occurs in 10–15 % of
this patients group [16–18, 19••, 20•, 21••, 22•, 23•, 24•,
25•]. Occasionally, dilated cardiomyopathy or hypertrophic
cardiomyopathy may also present with chest pain with un-
obstructed coronaries.
TCM or stress cardiomyopathy is a subtype of MI with
unobstructed coronary artery, and defined by the character-
istic wall motion abnormality that is, by definition, revers-
ible and transient. The condition usually has a favorable
prognosis compared to the other conditions. It is often,
but not always, provoked by an emotional stress or respira-
tory distress. Several mechanisms have been hypothesized
for TCM, including plaque disruption, multivessel spasm,
baroreflex abnormalities, and catecholamine toxicity. It re-
mains unclear whether TCM occurs due to one or multiple
mechanisms in individual patients.
TCM is characterized by mid-cavity to apical regional wall
motion abnormalities (Bapical ballooning^) with sparing of
the left ventricular basal segments. This can be identified by
LVangiogram, as well as transthoracic echocardiography. The
added diagnostic value of CMR is in its (1) high spatial reso-
lution, 3D image acquisition, and (2) non-invasive myocardial
tissue characterization. The former results in a clear detection
of cardiac chambers and endocardial contours, whilst the latter
allows the detection of myocardial edema (markedly present
in TCM) and myocardial scarring (usually absent in TCM)
[48••]. Typically, T2-weighted sequences are used to image
myocardial edema and it commonly identifies the presence of
circumferential and transmural myocardial edema of the api-
cal tomid-cavity myocardiummatching with the regional wall
motion abnormalities [49••]. Since myocardial edema is a
transient phenomenon, it is advisable that CMR imaging is
carried out within the first few weeks from the acute presen-
tation. Myocardial edema resolves in 2–3 months without any
myocardial scarring and with complete functional recovery
[49••]. A few studies have shown the presence of subtle late
gadolinium enhancement in TCM [50•], but experimental data
shows that delayed washout of gadolinium may be caused by
increased interstitial water content such that associated with
transient myocardial edema [51]. The subtle changes are
called myocardial edema-related LGE and they do not repre-
sent myocardial necrosis. The distribution of myocardial ede-
ma matching the wall motion abnormalities with no or subtle
LGE helps in distinguishing TCM from myocardial infarction
and myocarditis.
Risk Stratification with CMR in ACS with Unobstructed
Coronaries
ACS with unobstructed coronary arteries is a common clinical
entity encountered in day-to-day clinical practice. The mean
Fig. 4 A 70-year-old lady with
Tako-Tsubo cardiomyopathy. a
Four-chamber view showing mid-
apical myocardial edema in T2-
weighted sequences. b No
evidence of significant LGE in the
T1-weighted inversion recovery
post-contrast sequences
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age of presentation is usually lower than ACS with
obstructed coronaries [52•]. Except for cigarette smoking
[53], the common risk factors for CAD such as hyperten-
sion, diabetes mellitus, and hyperlipidemia are less present
than in the obstructed coronary artery group [54]. ACS with
unobstructed coronaries poses a clinical dilemma, as the
underlying diagnosis is variable and often unclear. Accu-
rate diagnosis is not only important for initiation of appro-
priate treatment, but may also have long-term implications
for the patient. Contrary to popular belief, the 1-year mor-
tality in the overall group was shown to be non-negligible
in a recent systematic review [15••]. Diagnosis is crucial as
a completely normal CMR scan is associated with a good
prognosis as demonstrated by the study by Chopard et al.
[21••]. CMR and its unique non-invasive myocardial tissue
characterization do not just have a diagnostic role but it has
a potential role in risk stratification.
Risk Stratification in Myocarditis
Clinical presentation of myocarditis can be varied ranging
from benign disease with preserved cardiac function to
more aggressive form associated with severe LV/RV dys-
function (like giant cell myocarditis). Recent literature on
myocarditis delineates its possible malignant side. Myocar-
ditis was the third leading cause of sudden death after hy-
pertrophic cardiomyopathy and congenital/atherosclerotic
coronary artery disease, as demonstrated in a clinical case
series of sudden deaths in young competitive athletes [55].
Myocarditis is responsible for 5 to 20 % of sudden deaths as
demonstrated in the autopsy studies of young adults [56]. It
may also resolve spontaneously without specific treatment
in patients presenting with mild symptoms and minimal
ventricular dysfunction [40••]. In up to 30 % of cases,
biopsy-proven myocarditis can progress to DCM and is
associated with a poor prognosis [40••]. CMR with its su-
perior tissue characterization property can delineate the se-
verity of myocarditis, thereby guiding in the management
and in risk stratification. A recent study by Grun et al. has
shown the presence of LGE is the best independent predic-
tor of all-cause mortality and of cardiac mortality in 222
consecutive patients with biopsy proven viral myocarditis
[57••]. LGE performed better than the traditional markers
like LV ejection fraction, LV end diastolic volume, and
NYHA symptom class. Moreover, normal CMR in patients
with clinically suspected myocarditis, is associated with a
good prognosis independent of their clinical symptoms and
other findings [58••]. Thus CMR may help to distinguish a
benign from malignant form of myocarditis. Prompt CMR
diagnosis of an aggressive myocarditis may led to in initi-
ation of appropriate therapy like immunosuppressants, ear-
ly referral for myocardial biopsy or help in MR guided
biopsy. Response to immunosuppressive therapy has been
reported mainly in chronic virus-negative forms, in giant
cell myocarditis, and in active myocarditis defined as auto-
immune (e.g. virus-negative and autoantibody positive)
[40••].
Risk Stratification in MI
CMR can also help in risk stratification in MI. In addition to
help achieving the diagnosis, the better tissue characteriza-
tion properties allow accurate assessment of infarct size
(LGE) and myocardial salvage. The area of myocardial ede-
ma delineated by T2-weighted CMR corresponds to the
myocardial area at risk (AAR). The presence and extent of
myocardial salvage can also be derived with CMR by
subtracting the infarcted area from the AAR [59]. There is
increasing data on the prognostic value of CMR-derived in-
farct size and myocardial salvage [60, 61•]. Microvascular
obstruction (MVO), characterized by hypoenhanced core
within myocardial infarction scar (hyperenhancement) on
rest first-pass perfusion or LGE imaging, can occasionally
be demonstrated. The presence and extent of MVO after
AMI is associated with adverse LV remodeling and poor
clinical outcome [62–64], and myocardial segments with
MVO at presentation are more likely to develop wall thin-
ning and fail to demonstrate functional recovery [65].
Nijveldt et al. confirmed that MVO in LGE proved a more
powerful predictor of global and regional functional recov-
ery than the transmural extent of infarction.
CMR can potentially diagnose the complications of MI.
CMR is superior to echocardiography for the identification
of ventricular thrombi, particularly when they are small and
apical. They are easily identifiable early after contrast ad-
ministration when both the cavity and the myocardium still
appear bright, whilst the thrombus appears hypointense
(lack of contrast uptake given that it is avascular) [66, 67].
CMR is also able to detect other complications of MI in-
cluding ventricular aneurysm, pseudoaneurysm, papillary
muscle infarction with subsequent mitral regurgitation, etc.
Risk Stratification in TCM
Although TCM is usually considered to be a benign revers-
ible condition, its arrhythmic risk is increasingly recog-
nized. There are promising new CMR analyses which
may help to risk stratify the patients with potential higher
arrhythmic risk [68••].
Deep T-wave inversion and QTc interval prolongation
on ECG may be observed in TCM [69•, 70]. Malignant
arrhythmias including torsades de pointes (TdP) caused
by repolarization abnormalities and QTc prolongation, can
be seen in up to 8 % of cases [71••]. In one meta-analysis,
sudden cardiac death (SCD) after TCM has been reported in
1.1 % during the index episode, with a further 0.5 % of
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patients suffering a SCD weeks to months later [72••]. The
study primarily looked at the relationship between TCM
and ventricular arrhythmias, reviewing a total 816 pub-
lished cases. VF was reported in 15 cases (prevalence of
1.8 %) and VT was reported in 18 (2.2 %) [72••].
The T-wave inversion and QT interval prolongation in typ-
ical TCM is thought to be caused by an intra-cardiac gradient
(apico-basal) of myocardial edema which, in turn, gives rise to
regional dispersion of action potential durations [73]. A study
by Perazzolo Marra et al. looked at the ECG and CMR find-
ings in 20 consecutive TCM patients. A linear correlation of
the apical-basal ratio of T2-weighted signal intensity with
ECG repolarization indices such as negative T-wave magni-
tude, sum of the amplitudes of negative T-waves, and maxi-
mum corrected QT interval has been shown [49••]. Interest-
ingly, the repolarization changes were unrelated to either late
gadolinium enhancement or quantitative cine parameters.
Hence, the T2-weighted signal intensity gradient can be po-
tentially used as a marker of malignant arrhythmia.
CMR can also provide additional information on the pres-
ence of LV apical thrombus, valvular abnormalities, and LV
outflow tract obstruction. Some of these findings are also di-
rectly linked to adverse prognosis.
Conclusion
In the context of ACS with unobstructed coronary arteries,
CMR has a potentially important diagnostic role, especially
in distinguishing ischemic from non-ischemic causes, thereby
guiding management. CMR can also potentially help in risk
stratification or prognostication in this cohort. Hence, it
should be strongly considered in all patients presenting with
troponin-positive chest pain with unobstructed coronaries
aiming at achieving a final diagnosis. However, this is yet to
be translated into routine clinical practice, particular within
institutions, which do not have readily access to CMR.
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